Nyxoah (NYXH) Cash from Operations Growth (1y) (2022 - 2026)
Nyxoah (NYXH) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 186.74% |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | 29.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.55% |
| Dec 31, 2025 | -975.30% |
| Sep 30, 2025 | 817.93% |
| Jun 30, 2025 | -57.46% |
| Mar 31, 2025 | 45.34% |
| Dec 31, 2024 | 84.10% |
| Sep 30, 2024 | -124.27% |
| Jun 30, 2024 | -6.41% |
| Mar 31, 2024 | 16.50% |
| Dec 31, 2023 | -724.51% |
| Sep 30, 2023 | 792.50% |
| Jun 30, 2023 | -122.33% |
| Mar 31, 2023 | 85.80% |
| Dec 31, 2022 | -6.37% |
| Sep 30, 2022 | 71.89% |
| Jun 30, 2022 | -208.66% |
| Mar 31, 2022 | 226.03% |